Home / Recalls / Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. / D-0467-2024

D-0467-2024 Class III Ongoing

Recalled by Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. — Tokushima, N/A

Recall Details

Product Type
Drugs
Report Date
May 1, 2024
Initiation Date
April 9, 2024
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
N/A

Product Description

Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (NDC 59148-008-95), RX only, Otsuka America Pharmaceutical, Inc.

Reason for Recall

Cross Contamination with Other Products

Distribution Pattern

USA nationwide.

Code Information

Lot #: a) ALS00422A, Exp 04/30/2025; ALS00523A, Exp 11/30/2025; b) 1K77YUD1H1A, Exp 11/30/2024

Other recalls by Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.

  • D-0466-2024 Class III — Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Ots (April 9, 2024)
  • D-0468-2024 Class III — Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Ot (April 9, 2024)
  • D-0469-2024 Class III — Abilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Ot (April 9, 2024)